According to a report from Reuters, the President claimed that these drugs would cost $150 out-of-pocket. As of the time of ...

EMD Serono's agreement with the US government aims to expand IVF therapy access for 10 million women, offering significant ...

In today’s Pharmaceutical Executive Daily, we explore how antibody-drug conjugate collaborations are moving beyond oncology ...

Peptilogics Founder, CEO, Jonathan Steckbeck, explained that PLG0206 stands apart from current treatments, while the ...

Veradermics raised $150 million to advance VDPHL01, an oral minoxidil treatment for hair regrowth, through Phase III trials ...

Boehringer Ingelheim and AimedBio collaborate on ADC therapy targeting a protein involved in cancer growth, aiming to enhance ...

In today’s Pharmaceutical Executive Daily, we explore how pharma leaders are rethinking workforce development at the ...

Learn what makes an AI roleplay solution actually move the needle in pharma field team performance. Lead with insight with ...

Pre-clinical data supports ECRIs' broad-spectrum attack on the IgE axis, distinct from conventional anti-IgE therapies, ...

President Trump’s latest attempt at implementing International Reference Pricing- based (IRP-) methodology to regulate drug ...

Bristol Myers Squibb's acquisition of Orbital Therapeutics includes OTX-201, a next-gen CAR T-cell therapy, and a proprietary ...

Shana Tetrault, PhD, Director of Product Marketing at Quanterix, discussed challenges in positioning Simoa in the precision ...